Edgewise Therapeutics, Inc. (EWTX) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Edgewise Therapeutics, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -15.23x | -18.44x | -6.96x | -7.08x | -17.67x | -86.58x |
| P/B Ratio | 4.89x | 5.37x | 2.19x | 1.38x | 2.76x | -44.18x |
| P/S Ratio | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x |
| Profitability | ||||||
| Gross Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Operating Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| EBITDA Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Liquidity | ||||||
| Current Ratio | 19.85x | 19.93x | 19.50x | 21.53x | 26.97x | 29.86x |
| Quick Ratio | 19.85x | 19.93x | 19.50x | 21.53x | 26.97x | 29.86x |
| Leverage | ||||||
| Debt/Equity | 0.01x | 0.01x | 0.02x | 0.01x | 0.00x | -4.79x |
YoY = year-over-year change. Source: FMP..